The level of proteinuria and the state of endothelial function in patients with chronic kidney disease combined with subclinical hypothyroidism under the influence of combined antihypertensive therapy.
DOI:
https://doi.org/10.26641/2307-0404.2018.2(part1).129510Ключевые слова:
chronic kidney disease, arterial hypertension, subclinical hypothyroidism, combined antihypertensive therapyАннотация
Our aim was to assess the level of proteinuria and changes in vascular endothelial function in patients with chronic kidney disease (CKD) in combination with subclinical hypothyroidism (SHT) under the influence of antihypertensive combination therapy (valsartan 160 mg and amlodipine 5 mg). We examined 48 patients with CKD I-II stages and AH 1 and 2 degrees. Depending on the functional state of the thyroid gland, patients were divided into 2 groups. Within 12 weeks patients took a fixed combination of amlodipine 5 mg and valsartan 160 mg. Target BP levels were achieved in 19 (86.3%) patients of the main group and 22 (84.6%) of the comparison group. More often violation of brachial artery flow-mediated dilation and higher level of daily proteinuria were found in the main group patients. At the end of the study, the level of daily proteinuria in the main group decreased by 46.03% (p<0.01), and in the comparison group – by 55.3% (p<0.01). SHT can be considered as an additional factor that affects the course of CKD and AH by worsening the state of endothelial function and increasing the level of daily proteinuria. Combination of valsartan 160 mg and amlodipine 5 mg has lead to achieving of target blood pressure levels, improving of endothelial function and decreasing of daily proteinuria in both groups.
Библиографические ссылки
Kuryata OV, Karapetjan KG, Bardachenko NI, Garmish IP. [Possibilities of correction of cognitive functions and anxiety-depressive disorders in the complex therapy of arterial hypertension, depending on the functional state of the kidneys]. Journal of neuroscience of BM Mankovskyi. 2015;3(3):5-10. Russian.
Zaremba Je, Zaremba-Fedchyshyn O, Virna M. [Optimization of combined antihypertensive therapy in patients with arterial hypertension, depending on the indicators of daily blood pressure monitoring]. Semejnaja medycyna. 2017;2 (70):67-71. Ukrainian.
Kuryata OV, Garmish IP. [The effectiveness of combined antihypertensive therapy in patients with chronic kidney disease combined with subclinical hypothyroidism]. Semeynaya meditsina. 2017;3(71):22-27. Ukrainian.
Кushnir JS. [Hemodynamics, functional state of the endothelium, kidneys and platelets depending on the body mass index in patients with chronic heart failure with preserved systolic function]. Medicni perspektivi. 2014;ХІХ(1):29-36. Ukrainian.
Lapshin OV. [Combined antihypertensive therapy - a modern trend of treatment]. Liky Ukrainy. 2013;1(167):30-37. Ukrainian.
Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of theAmericanCollegeof Cardiology. American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;13.
Cooper D, Biondi B. Subclinical thyroid disease. Lancet. 2012;379(9821):1142-54.
Leung AA, Daskalopoulou SS, Dasgupta K, et al. Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. Canadian Journal of cardiology. 2017;33(5):557-76.
Chongol M, Lippi G, Salvagno G, Zoppini G, Michele M, Giovanni T. Prevalence of Subclinical hypothyroidism in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008;3(5):1296-300.
Загрузки
Как цитировать
Выпуск
Раздел
Лицензия
Copyright (c) 2018 Medicni perspektivi (Medical perspectives)
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
